Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section.
Postoperative Pain
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring caesarean section, postoperative pain, transmuscular quadratus lumborum block, reduction of opioid consumption
Eligibility Criteria
Inclusion Criteria:
- Pregnant women scheduled for elective Caesarean Section in spinal anaesthesia.
- Have received thorough information, orally and in written, and signed the "Informed Consent" form on participation in the trial
Exclusion Criteria:
- Inability to cooperate
- Inability to speak and understand Danish
- Allergy to local anaesthetics or opioids
- Daily intake of opioids
- Local infection at the site of injection or systemic infection
- Difficulty visualisation of muscular and fascial structures in ultrasound visualisation necessary to the block administration
Sites / Locations
- ZUH
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Active
Placebo
Active bilateral ultrasound-guided transmuscular quadratus lumborum (TQL) block. 60 ml ropivacaine 0,375% single shot. In both arms, the participants receive 1g Acetaminophen and 400 mg Ibuprofen / 100 mg Celebra. Morphine will be administered IV as part of a PCA-pump regimen or additionally after contact with the nursing staff as it is the standard treatment.
Placebo bilateral ultrasound-guided transmuscular quadratus lumborum (TQL) block. 60 ml saline single shot. In both arms, the participants receive 1g Acetaminophen and 400 mg Ibuprofen / 100 mg Celebra. Morphine will be administered IV as part of a PCA-pump regimen or additionally after contact with the nursing staff as it is the standard treatment.